The Lamira nebulizer handset with an eBase® Controller is intended to administer ARIKAYCE® as an aerosol for inhalation.
Lamira is an eFlow® Open System Nebulizer.
More information
ARIKAYCE is marketed in the US, EU, and Japan by Insmed, a global biopharmaceutical company headquartered in the United States.
For additional information please refer to the package leaflet of the medicinal product.
Further information:
www.insmed.com
www.arikayce.com
News release FDA approval
News release European Commission approval
News release Japan's Ministry of Health approval
The MAGNAIR nebulizer handset with an eLete® Controller is intended to administer LONHALA® MAGNAIR® as an aerosol for inhalation.
MAGNAIR is an eFlow® Closed System Nebulizer.
More information
LONHALA® MAGNAIR® Inhalation Solution is marketed by Sunovion Pharmaceuticals in the US.
For additional information please refer to the package leaflet of the medicinal product.
Further information:
www.sunovion.com
https://www.ds-pharma.com/ir/news/pdf/ene20120831.pdf
Get a detailed look at the device features of LONHALA MAGNAIR.
Learn about the evolution of nebulizer technology leading up to the MAGNAIR Nebulizer System.
Watch excerpts from an instructional video on how to set-up, administer, and clean LONHALA MAGNAIR, which is included in the US approved prescription packaging.
The Zirela nebulizer handset with an eBase® Controller is intended to administer QuinsairTM as an aerosol for inhalation.
Zirela is an eFlow® Open System Nebulizer.
More information
Quinsair 240 mg nebulizer solution is marketed in the EU (MAH: Chiesi Limited) and Canada (MAH: Horizon).
For additional information please refer to the package leaflet of the medicinal product.
Further information:
www.horizonpharma.com
https://globenewswire.com/news-release
The Tolero nebulizer handset with an eBase® or eTrack® Controller is intended to administer Vantobra® as an aerosol for inhalation.
Tolero is an eFlow® Open System Nebulizer.
More information
Vantobra 170 mg nebulizer solution was developed by PARI Pharma GmbH and is marketed in several EU countries (MAH: PARI Pharma GmbH) and in Switzerland (MAH: PARI Swiss AG). Each package of Vantobra provides the patient with a new Tolero nebulizer handset.
For additional information please refer to the package leaflet of the medicinal product.
Further information:
www.pari.com/vantobra-de/home [German page]
The eFlow®rapid nebulizer handset with an eBase® Controller is intended to administer nebulizer solutions or suspensions as an aerosol for inhalation approved for the treatment of diseases of the lower airways. For example, ColiFin® / Colfinair®, a product of PARI Pharma.
eFlow®rapid is an Open System Nebulizer.
More information
Each package of ColiFin / Colfinair contains saline solution for reconstitution and a new eFlow®rapid nebulizer handset. Because of this unique selling proposition, the specific drug and device concept, marketed in several countries in the EU, is highly accepted.
For additional information please refer to the package leaflet of the medicinal product.
Further information:
www.pari.com/colifin-de/home [German page]
www.pari.com/colifin-at/home [Austrian page]
www.pari.com/colifin-es [Spanish page]
The Altera nebulizer handset with an eBase® Controller is intended to administer Cayston® as an aerosol for inhalation.
Altera is an eFlow® Open System Nebulizer.
More information
Cayston 75 mg powder and solvent for nebulizer solution is marketed by Gilead Sciences in the US, EU, and Canada.
For additional information please refer to the package leaflet of the medicinal product.
Further information:
www.cayston.com
ARIKAYCE is a registered trademark of Insmed Incorporated
Cayston® is a registered trademark of Gilead Sciences Inc.
Lonhala® is a registered trademark of Sunovion Pharmaceuticals Inc.
SUNOVION is a registered trademark of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Sumitomo Dainippon Pharma Co., Ltd.
QUINSAIR™ is a trademark of Horizon
eFlow®, eBase®, eLete®, eTrack®, ePort®, eRapid®, Altera®, Zirela®, Tolero®, Magnair®, Lamira®, Vantobra®, ColiFin®, Colfinair® and Vibrent® are registered trademarks of PARI Pharma GmbH
Contact us
Do you have any questions about our technology, partnering approach and services?
Please contact us!
eFlow-partneringpari.com
© 2023 PARI GmbH Spezialisten für effektive Inhalation
